Login

Red Eagle Mining's Progress and Plans in Colombia 00:10:00

Share On Facebook Share On Twitter

Ian Slater, CEO of Red Eagle. Red Eagle Mining Corp. is a Canadian gold exploration and development company focused on developing the San Rosa gold project in Colombia's Antioquia department. The company also holds a portfolio of exploration properties throughout the country including the Pavo Real gold project in Tolima department.

Recent Videos

00:10:00
Thomas Olin Highlights Kancera’s Latest Advances and Strategic Focus | Dr. Thomas Olin, CEO , Kancera AB.
00:10:00
Pablo Pereiro Discusses Squirrel Media’s 63% Profit Growth and 14.7% Stock Surge | Pablo Pereiro , CEO , Squirrel Media SA.
00:10:00
Steve Oliver of musicMagpie Discusses Circular Economy and Company's Growth Strategy | Steve Oliver , CEO , musicMagpie PLC.
00:10:00
Revolutionizing Healing with Naturally Derived Psychedelics | Benjamin Lightburn, CEO , Filament Health Corp.
00:10:00
SMC Global Securities Launches New Office at Bahu Plaza, Jammu, to Promote Share Market Investments | Ajay Garg , CEO , SMC Global Securities Ltd.
00:10:00
Exploring Demoralization Syndrome Treatment with Filament Health’s Psilocybin Trials | Benjamin Lightburn, CEO , Filament Health Corp.
00:10:00
BioInvent CEO Explores Portfolio Strategy and Upcoming Breakthroughs | Dr. Martin Welschof, CEO , BioInvent International AB.
00:10:00
Piotr Figarski Discusses Image Power's 2022 Results and Future Trends | Piotr Figarski, Vice President , Image Power SA.
00:10:00
Pablo Pereiro and María Bonaria Fois Discuss Squirrel Media's Strategic Acquisition of Mondo TV Studios | Pablo Pereiro , CEO , Squirrel Media SA.
00:10:00
Lexington Gold Set to List on London AIM Exchange After Reverse Takeover | Dr. Bernard Olivier, CEO , Lexington Gold Ltd.
00:10:00
Thomas Olin, CEO of Kancera AB, Discusses Strategic Advances in Biopharma Innovation | Dr. Thomas Olin, CEO , Kancera AB.
00:10:00
Leading the Charge in the Psychedelic Movement with Filament Health | Benjamin Lightburn, CEO , Filament Health Corp.
00:10:00
Pini Mandel on the Power of Dynamic Pricing to Boost Retail KPIs and Customer Satisfaction | Pini Mandel , CEO , Quicklizard Ltd.
00:10:00
Jean Michel Ng Tseung, New CEO of MCB Group, Shares Vision for a Sustainable Future | Jean Michel Ng Tseung , CEO , MCB Group Ltd.
00:10:00
Viktor Garmiani Unveils Candles Scandinavia’s Q4 Report Highlights | Viktor Garmiani, CEO , Candles Scandinavia AB.
00:10:00
Squirrel Media's Record-Breaking Year: CEO Pablo Pereiro Discusses Key Strategies and Global Expansion | Pablo Pereiro , CEO , Squirrel Media SA.

Suggestions

00:10:00
Savant: Your Trusted Partner for Comprehensive Financial Planning
00:10:00
Archer Exploration: Advancing Nickel Sulfide Projects in Ontario and Quebec
00:10:00
Funds businesses transforming industry verticals|Will McClelland,Co-Founder & General Partner,Elizabeth Street Ventures
00:10:00
India’s Growing Edge: SVP Global’s CFO OP Gulia Explores Benefits of the China +1 Strategy | OP Gulia, CFO, SVP Global Ventures Pvt Ltd.
00:10:00
Claudio Erba, CEO, and Alessio Artuffo, CRO of Docebo Inc., provide insights in "The View From The C-Suite," juxtaposed with Warren Buffett's endorsement of Greg Abel for Berkshire Hathaway.|Claudio is the founder and CEO of Docebo
00:10:00
Investors Reveal How They Evaluate the Startup Landscape|Mike Edelhart,Managing Partner,Ataraxia VC
00:10:00
Lexington Gold Upgrades Resource at Jones-Keystone Loflin, Assay Results from Argo Asset Show Promise | Dr. Bernard Olivier, CEO , Lexington Gold Ltd.
00:00:00
Dr Greg van Wyk, CEO, Noxopharm Ltd
00:10:00
Professor David E. Bernstein on the Boundaries of Anti-Discrimination Laws|David E. Bernstein, Professor, George Mason University
00:10:00
A snapshot of the stocks on the move, featuring BluGlass Limited, Vection Technologies Ltd (ASX:VR1), and Lake Resources, highlights significant market activity and trends.
00:10:00
CDL is a no-fee/no-equity organization that delivers a 9-month objectives-based mentoring program|Sonia Sennik,Executive Director,Creative Destruction Lab
00:10:00
Advancing Gene Therapy for Ocular Diseases: Lunar Phase 2 Trial Design and Clinical Significance | Laurent Fischer, CEO, Adverum Biotechnologies Inc .

© 2017 - Townhall + Tv